Director Woody Fralin buys 20,000 AVITA Medical (RCEL) shares

Rhea-AI Filing Summary

AVITA Medical, Inc. director Woody Joseph Fralin bought a total of 20,000 shares of Common Stock in open-market transactions. The purchases occurred on June 1 and 2 at prices between $4.18 and $4.34 per share, bringing his direct holdings to 20,000 shares.

Insider Trade Summary

Net Buyer: 20,000 shares ($84,937)

Net Buy 4 txns

Insider Woody Joseph Fralin

Role null

Bought 20,000 shs ($85K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,000	$4.1802	$21K
Purchase	Common Stock	5,000	$4.2071	$21K
Purchase	Common Stock	5,000	$4.34	$22K
Purchase	Common Stock	5,000	$4.26	$21K

Holdings After Transaction: Common Stock — 15,000 shares (Direct, null)

Footnotes (1)

Key Figures

Total shares purchased: 20,000 shares Holdings after transactions: 20,000 shares Purchase on 2026-06-02: 5,000 shares at $4.2071/share +3 more

6 metrics

Total shares purchased 20,000 shares Net open-market purchases reported in Form 4

Holdings after transactions 20,000 shares Directly owned Common Stock after June 2 trades

Purchase on 2026-06-02 5,000 shares at $4.2071/share Open-market purchase of Common Stock

Second purchase on 2026-06-02 5,000 shares at $4.1802/share Open-market purchase of Common Stock

Purchase on 2026-06-01 5,000 shares at $4.2600/share Open-market purchase of Common Stock

Second purchase on 2026-06-01 5,000 shares at $4.3400/share Open-market purchase of Common Stock

Key Terms

open-market purchase, Common Stock, non-derivative, direct ownership

4 terms

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"transaction_type": "non-derivative""

direct ownership financial

"direct_or_indirect": "D" and ownership_type": "direct""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Woody Joseph Fralin

(Last) (First) (Middle)

C/O AVITA MEDICAL 28159 AVENUE STANFORD

SUITE 220

(Street)

VALENCIA CALIFORNIA 91355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AVITA Medical, Inc. [ RCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		P		5,000	A	$4.34	5,000	D
Common Stock	06/01/2026		P		5,000	A	$4.26	10,000	D
Common Stock	06/02/2026		P		5,000	A	$4.1802	15,000	D
Common Stock	06/02/2026		P		5,000	A	$4.2071	20,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nicole Kelsey, by power of attorney	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did AVITA Medical (RCEL) report for Woody Joseph Fralin?

Director Woody Joseph Fralin reported buying a total of 20,000 AVITA Medical common shares in open-market transactions. These purchases were made over two days and increased his directly held position to 20,000 shares after the reported trades.

On what dates did Woody Joseph Fralin buy AVITA Medical (RCEL) shares?

Woody Joseph Fralin bought AVITA Medical common shares on June 1 and June 2. The Form 4 shows two separate purchase batches on each date, all classified as open-market transactions in the company’s Common Stock.

How many AVITA Medical (RCEL) shares did Woody Joseph Fralin purchase in total?

Across four open-market trades, Woody Joseph Fralin purchased 20,000 shares of AVITA Medical Common Stock. Each transaction involved 5,000 shares, and together they raised his directly owned stake to 20,000 shares following the final reported trade.

What prices did Woody Joseph Fralin pay for AVITA Medical (RCEL) shares?

The reported purchase prices ranged from about $4.18 to $4.34 per share. Individual trades were recorded at $4.3400, $4.2600, $4.2071, and $4.1802, reflecting actual execution prices for each 5,000-share open-market transaction.

How many AVITA Medical (RCEL) shares does Woody Joseph Fralin own after these trades?

After completing the reported purchases, Woody Joseph Fralin directly owns 20,000 shares of AVITA Medical Common Stock. The Form 4 shows this as his total direct holding following the last transaction on June 2, with all reported ownership classified as direct.

Were Woody Joseph Fralin’s AVITA Medical (RCEL) trades derivative or non-derivative?

All of Woody Joseph Fralin’s reported AVITA Medical trades were in non-derivative Common Stock. The filing classifies each as an open-market purchase of the underlying common shares, with no related option exercises or derivative security activity disclosed.